Studies critical genomic changes implicated in ovarian and breast cancers.
At the Jackson Laboratory for Genomic Medicine, I am involved in several projects that explore the genome-wide patterns of genetic and transcriptional alterations characterizing human cancers. In particular,I am interested in the identification of key regulatory genes and/or pathways as well as complex rearrangement profiles, which may explain tumor initiation and progression as well as provide valuable targets for the development of novel therapeutic approaches and prognostic biomarkers. At present, I am investigating critical genomic aberrations implicated in ovarian and breast cancer tumorigenesis. By exploiting next-generation sequencing technologies combined with in vitro cell culture models and in vivo patient-derived xenografts, I aim at a better understanding of the individuality of cancer genomes and at the development of novel approaches toward the personalized management of cancer patients.
April 2010 to September 2010 - Awarded Annabel McEnery Children's Cancer Fund
2008 - Regional prize winners in Biotechnology YES business course, Newcastle/London, UK
2008 - ICH open day poster special commendation
October 2006 to March 2010 - Awarded Olivia Hodson Cancer Fund PhD studentship
2004 - Best contribution award at the IX National Congress of the Italian Association of Neuro-Oncology